title: Cystic fibrosis transmembrane conductance regulator biomarkers in 'real life': can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
authors.affiliation: CF-Center, Children's Hospital, University of Cologne, Kerpener Str. 62, 50924 Cologne, Germany Silke.vanKoningsbruggen@uk-koeln.de.
authors.forename: Silke
authors.initials: S
authors.lastname: van Koningsbruggen-Rietschel
authors.affiliation: Department of Pediatrics, Justus-Liebig-University Giessen, Giessen, Germany.
authors.forename: Lutz
authors.initials: L
authors.lastname: Naehrlich
mesh_terms: D000293:Adolescent; D000328:Adult; D000627:Aminophenols / Q000494:pharmacology / Q000627:therapeutic use*; D015415:Biomarkers / Q000378:metabolism; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation; D015363:Quinolones / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000627:Aminophenols; D015415:Biomarkers; D015363:Quinolones; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor